Success Stories: A Ph.D. student in Biomedical Engineering from Taiwan Obtained NIW Approval without RFE, Thanks to Our Team’s Diligent Efforts

Posted by wegreened on February 15, 2023 in NIW, Medicine (Pharmaceutics, Pharmacology, Oncology, Pharmacognosy, Biomedical Engineering, Biomedicine)

Client’s Testimonial:

“Thank you very much for your help.”

On May 21^st, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Ph.D. student in the Field of Biomedical Engineering (Approval Notice).

General Field: Biomedical Engineering

Position at the Time of Case Filing: Ph.D. student

Country of Origin: Taiwan

State of Residence at the Time of Filing: Maryland

Approval Notice Date: May 21^st, 2022

Processing Time: 15 months, 14 days

Case Summary:

The I-140 NIW (National Interest Waiver) petition of a Taiwanese expert in biomedical engineering was prepared by our team by including the following details from his academic and professional documents:

His proposed endeavor was to continue his full characterization of the cellular and genetic mechanisms/determinants related to cancers that strongly interact with their surrounding microenvironment in order to improve treatment strategies, mitigate costs, and preserve human life. Among other applications, his research is relevant to reducing the immense national and global burden of cancer. His research is thus immensely important as it bolsters current international efforts to enhance cancer treatments and reduce the disease’s overall burden.
His successes in slowing metastasis and identifying key therapeutic targets confirm that he is a leader in cancer research, and biomedical engineering more broadly. This is why one of his 4 recommendations had the following to say of him:

“[The client’s] research has proven to be beneficial in better understanding how cancers develop and progress. More specifically, he has focused his efforts on forms of cancer that heavily interact with the surrounding organs, often leading to the spread of cancer outside of the original location. These forms of cancer have proven particularly difficult to treat, and [the client’s] focus on this area is therefore invaluable. His work in the biomedical engineering community is essential for progress, delivering experimental data and laboratory methods that significantly enhance cancer treatment methods.”

His proposed endeavor also has broad implications for the United States, since in this country, the high prevalence of cancer places an immense burden on medical and economic resources.
Additionally, his research has resulted in 9 peer-reviewed journal articles (5 of them first-authored) which have been cited a total of 102 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of biomedical engineering.
At the same time, he has pursued research directly related to his proposed endeavor for 8 years, giving him the necessary experience to continue working in the field and hence benefiting the country.

We are glad to have seen his approval through and we wish him all the best in his future endeavors.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%